139 related articles for article (PubMed ID: 37902721)
1. Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells.
Cao TM; Chen D; Barnard GC; Shen A
Biotechnol Bioeng; 2024 Jan; 121(1):395-402. PubMed ID: 37902721
[TBL] [Abstract][Full Text] [Related]
2. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
4. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
5. Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production.
Johari YB; Pohle TH; Whitehead J; Scarrott JM; Liu P; Mayer A; James DC
Biotechnol J; 2024 Jun; 19(6):e2300685. PubMed ID: 38900035
[TBL] [Abstract][Full Text] [Related]
6. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
7. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
8. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
9. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
10. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.
Xiao X; Li J; Samulski RJ
J Virol; 1998 Mar; 72(3):2224-32. PubMed ID: 9499080
[TBL] [Abstract][Full Text] [Related]
11. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors.
Handa A; Muramatsu SI; Qiu J; Mizukami H; Brown KE
J Gen Virol; 2000 Aug; 81(Pt 8):2077-2084. PubMed ID: 10900047
[TBL] [Abstract][Full Text] [Related]
13. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
14. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
15. Characterization of permanent cell lines that contain the AAV2 rep-cap genes on an Epstein-Barr-virus-based episomal plasmid.
Neyns B; Vermeij J; Teugels E; De Rijcke M; Hermonat P; De Grève J
Intervirology; 2001; 44(4):255-63. PubMed ID: 11509889
[TBL] [Abstract][Full Text] [Related]
16. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
Shi S; Mercer SA; Dilley R; Trippel SB
Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
[TBL] [Abstract][Full Text] [Related]
17. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
18. Promoter from Chinese hamster elongation factor-1a gene and Epstein-Barr virus terminal repeats concatemer fragment maintain stable high-level expression of recombinant proteins.
Sinegubova MV; Orlova NA; Vorobiev II
PeerJ; 2023; 11():e16287. PubMed ID: 37901457
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
[TBL] [Abstract][Full Text] [Related]
20. AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.
Su W; Seymour LW; Cawood R
Sci Rep; 2023 Dec; 13(1):21670. PubMed ID: 38066084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]